Endothelial progenitor cells as a cardiometabolic risk factor marker in prediabetes

Angeliki Angelidi1, Andreas Melidonis1, Ioannis Protopsaltis1

  • 1Diabetes Center, "Tzaneio" General Hospital of Piraeus; Greece.

Hormones (Athens, Greece)
|April 30, 2014
PubMed

Insights

Visceral fat is the primary factor influencing endothelial progenitor cell (EPC) levels in prediabetes. This finding links metabolic issues, cardiovascular risk, and vascular health in prediabetic individuals.

Area of Science:

  • Cardiovascular Research
  • Metabolic Syndrome Studies
  • Vascular Biology

Background:

  • Endothelial progenitor cells (EPCs) are emerging biomarkers for vascular integrity, atherosclerosis, and cardiovascular risk.
  • Understanding factors influencing EPC levels is crucial for managing prediabetes and associated risks.

Purpose of the Study:

  • To identify the key determinants of endothelial progenitor cell (EPC) levels in individuals diagnosed with prediabetes.
  • To explore the relationship between EPCs and traditional cardiovascular risk factors, metabolic parameters, and body fat distribution.

Main Methods:

  • Quantification of EPCs (CD34+CD133+VEGFR-2+) using flow cytometry in 39 prediabetic participants.
  • Assessment of traditional risk factors, hs-CRP, HOMA-IR, and anthropometric/ultrasonographic fat measurements.

Main Results:

  • Univariate analysis showed significant correlations between EPC levels and waist circumference, mean arterial pressure, total cholesterol, hs-CRP, HOMA-IR, and visceral fat.
  • Multivariate analysis identified visceral fat as the sole significant determinant of EPC levels (OR=0.79, p=0.032).

Conclusions:

  • Visceral fat is the principal determinant of endothelial progenitor cell (EPC) levels in prediabetes.
  • Visceral fat may bridge metabolic abnormalities, cardiovascular risk, and vascular homeostasis in prediabetic individuals.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75